A Study of Single and Multiple SC Doses of ALXN1830 in Healthy Adult Participants
Clinical trial NCT05254613 · TERMINATED
Trial details
- NCT number
- NCT05254613
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-12
- Primary completion
- 2021-01-22
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.